Collaborators wanted — 2026–2028 preparation phase

The pilot answers the biology.
This work answers everything else.

ADJUNCT-SYPH is a 24-month mechanistic pilot. In parallel, we are preparing the definitive dyadic RCT that must follow if the pilot succeeds — a trial that will randomise couples, not individuals, in a high-burden African setting. It needs to be co-built now, with the right people, in the open.

Context

Why this preparation phase exists

Dyadic trials fail when only the biology is ready

A trial that intervenes on a couple — particularly around sexual health in a setting with structural gender inequality — requires counselling protocols, safeguarding pathways, and community legitimacy that take years to build. Treating these as deliverables of the trial itself, rather than prerequisites, has historically produced trials that are either ethically fragile or unimplementable at scale.

The pilot window is the build window

The 24 months during which AMBSO and RHSP run the mechanistic pilot are the same 24 months during which the dyadic protocol, counselling curriculum, IPV-safeguarding pathway, and PPIE infrastructure must be co-designed. By the time the pilot reports its Stop/Go decision, the definitive trial protocol should be ready for submission — not still on a whiteboard.

Four parallel workstreams

What is being built — and where the gaps are

Co-designed dyadic counselling

Lead investigator and curriculum partners sought

What this is

A counselling protocol designed for couples in which one partner (the man) carries an intervention intended to benefit the other (the woman). The protocol must address informed consent that is genuinely dyadic, asymmetries in benefit and burden, what happens when partners disagree about participation, and how to handle disclosure of trial-related findings without weaponising them.

What we are not assuming

That existing dyadic counselling curricula from HIV-discordant couples research transfer directly. They may, partially. They may also import assumptions that do not hold for a microbiome-modifying device intervention with no immediate symptomatic benefit to the person wearing it.

Who we need

  • A senior co-investigator in dyadic or couples-based health interventions, ideally with sexual health or sub-Saharan African experience.
  • Behavioural scientists with expertise in informed consent in low-literacy and gender-asymmetric settings.
  • Curriculum developers who have built counsellor-training programmes for community health workers in East Africa.
  • Critical readers — researchers who have opposed dyadic trial designs in similar contexts and can stress-test the rationale.

What collaboration looks like

We are seeking partners now, during the pilot phase, to co-develop the dyadic counselling work package. Early involvement means shaping the framework from scratch. Collaboration results in co-authorship on the published work package and positions partners for named roles in the definitive trial preparation.

IPV safeguarding pathway

Highest-priority gap — safeguarding lead required

What this is

A documented, trial-integrated pathway for the identification, response, and longitudinal monitoring of intimate partner violence among enrolled couples. This includes baseline screening, protocols for what trial staff do when violence is disclosed or suspected, referral relationships with local services, staff training, and a framework for whether and when participation should be paused or withdrawn.

Why we are flagging this as critical

Any intervention that touches the sexual health of a couple in a setting with prevalent intimate partner violence carries a credible risk of inadvertently triggering or worsening it. A trial that does not have a robust, externally validated safeguarding pathway in place before first participant in is not ready to run, regardless of how compelling the biology is.

Who we need

  • An IPV researcher to lead this workstream — ideally someone who has built safeguarding pathways for HIV or SRH trials in East Africa.
  • Ugandan organisations with existing IPV response infrastructure (CEDOVIP, Raising Voices, UWONET, district-level GBV referral networks) — partnership, not consultation.
  • Safeguarding officers who have implemented and audited similar pathways and can contribute to protocol review.
  • A trauma-informed clinician advisor for staff training design.

What collaboration looks like

We are seeking this collaboration during the pilot phase. Partners co-design the safeguarding pathway from the ground up, with formal organisational agreements. The pathway is intended to be publishable as a standalone output and reusable beyond this trial.

PPIE — Patient and Public Involvement

Community partners and PPIE methodologist sought

What this is

A standing community advisory infrastructure — including, centrally, a panel of women from the Rakai catchment area whose partners would be the device-wearing participants. PPIE here is not a consultation box to tick at protocol finalisation. It includes co-design of recruitment materials, consent processes, results communication, and the framing of the device in local language and cultural context.

What we are explicitly avoiding

Token PPIE — a single workshop, an honorarium, a paragraph in the protocol. The dyadic nature of this trial demands that the women who would carry the downstream benefit or harm of the intervention have continuous, structured input from now until trial close-out.

Who we need

  • A PPIE methodologist to design the structure (panel composition, decision rights, remuneration, governance).
  • Ugandan community-based organisations and women’s groups with existing reach in the Rakai region.
  • A medical anthropologist or qualitative researcher familiar with the study area and the genital hygiene discourse there.
  • Translators and local knowledge holders to ensure trial materials are culturally legible, not just linguistically translated.

What collaboration looks like

We are seeking PPIE partners during the pilot phase to begin building the community infrastructure and consent processes that the definitive trial will require. Co-authorship on PPIE methods papers and a defined role in the definitive trial preparation.

Stakeholder and policy engagement

Implementation researchers and policy partners sought

What this is

Sustained engagement with the Uganda Ministry of Health, the National Drug Authority, district health offices, existing VMMC programme implementers, and religious and traditional leadership in the Rakai region. The goal is that — if the dyadic RCT proceeds and shows benefit — there is already a pathway to integration into existing STI control and maternal health programmes.

What this is not

A communications strategy. This is implementation science work: understanding the existing service architecture, identifying integration points, and building the relationships that make scale-up feasible rather than aspirational.

Who we need

  • Implementation scientists with experience embedding research in Ugandan health services.
  • Policy researchers tracking the WHO syphilis elimination agenda and national STI strategies in East Africa.
  • Partners inside existing VMMC delivery programmes who can advise on integration scenarios.
  • Health economists for the costing and cost-effectiveness work the definitive trial application will require.

What collaboration looks like

We are seeking implementation science partners during the pilot phase to begin stakeholder and policy engagement in parallel with biological data collection. Named workstream leads will have co-authorship on outputs and a defined role in the definitive trial preparation.

Transparency

What we are not doing — and why that matters

Circunaro SL has no role in psychosocial design

The device manufacturer (Circunaro SL) is not a named applicant on ADJUNCT-SYPH and will not participate in the design, conduct, or analysis of the counselling, IPV-safeguarding, or PPIE workstreams. Investigators considering collaboration on this work should not have to weigh industry influence in the components where their expertise sits.

We are not pre-committing to a trial design

The dyadic RCT protocol is being co-built. We have a working hypothesis but the counselling, safeguarding, and PPIE workstreams have genuine authority to shape the design — including, if warranted, to conclude that the proposed design should change substantially.

We are not assuming this is the right trial to run

The mechanistic pilot has explicit Stop/Go criteria. If the pilot does not meet Go criteria, the dyadic trial does not proceed, and the methods, pathways, and partnerships built during preparation are released as publishable outputs in their own right.

Get involved

Two pathways, depending on who you are

For researchers

Explore a co-investigator role

We are most interested in hearing from researchers in dyadic counselling, IPV and safeguarding, PPIE methodology, medical anthropology of sexual health, behavioural science, and implementation science in East Africa. Early-career researchers with relevant training are welcome — this is not gated to senior PIs.

Please write with a short note on your background, which workstream(s) you see yourself contributing to, and any constraints we should know about.

research@circunaro.com
For organisations, partners & co-investors

Partner with us

We are seeking partnerships with Ugandan community-based organisations, women’s groups, IPV response services, and existing VMMC programme implementers. Partnership means budgeted roles, shared decision rights on the workstreams that touch your community, and authorship on outputs you contribute to.

We are also open to conversations with funders and co-investors interested in complementary support for the preparation phase — particularly for IPV safeguarding infrastructure, PPIE remuneration, and the implementation-science engagement workstream. We are happy to share a preparation-phase budget summary, timeline, and milestone framework on request.

If your organisation already has community infrastructure in the Rakai region or in comparable settings, we would value an early conversation — including conversations that conclude this is not the right partnership.

research@circunaro.com

Trial registration pending — PACTR & ClinicalTrials.gov before first participant in.